Sign In

Marco Dotto

Senior consultant Business Development and Strategic Partnerships presso Health Catalyst

Professional Background

Marco Dotto is a highly accomplished serial entrepreneur with extensive expertise in the fields of genomics and healthcare. His career is distinguished by his passion for leveraging advanced technologies to revolutionize healthcare. As a co-founder and former CEO of Italy's first Next Generation Sequencing (NGS) companies, Marco has carved a niche in the healthcare landscape by delivering innovative solutions for diagnosis and treatment.

Marco's entrepreneurial journey encompasses several key domains within the genomics sector. He has been at the forefront of pioneering technologies in whole genome sequencing and interpretation. His commitment to improving patient outcomes is reflected through the development of diagnostic services for rare diseases, providing Direct-to-Consumer (DTC) personal genomics services, and implementing non-invasive prenatal tests. Furthermore, Marco has expanded his focus to include multi-omics analyses and liquid biopsy for oncological patients, effectively bridging the gap between technology and patient care.

With a wealth of experience in managing startups, scaling businesses, and facilitating exits, Marco has built a reputation as a mission-driven leader. His venture into the healthcare field is underscored by his goal to transform patients' lives, making groundbreaking technologies accessible and impactful. Throughout his career, he has successfully managed numerous clinical research projects, demonstrating his expertise in fostering strategic partnerships on a global scale.

Marco's current role as a Senior Business Development Consultant and strategic partnerships expert at Health Catalyst allows him to continue his pursuit of technological advancements in healthcare, positioning him as a catalyst for significant improvements in patient care.

Education and Achievements

Marco Dotto's educational background is deeply rooted in science and biotechnology, equipping him with the knowledge and skills necessary for success in his dynamic career. He attended the Liceo Scientifico Leonardo Da Vinci, where he earned a Scientific High School Degree in Science with an impressive score of 94/100.

He furthered his academic journey by obtaining a Bachelor of Science (B.S.) in Biotechnology from the Università degli Studi di Padova, followed by a Master of Science (M.S.) in Biotechnology and an additional M.S. in Industrial Biotechnology, specializing in Functional Genomics and Proteomics. His remarkable academic performance culminated in graduating with honors (110 cum laude), showcasing his dedication and expertise in the biotechnology field.

Additionally, Marco enhanced his education by pursuing a Master in Management at Fondazione Cuoa, further strengthening his ability to navigate the complexities of the biotech industry and manage successful businesses.

Key Achievements

Throughout his career, Marco Dotto has made significant strides in the biotechnology and healthcare sectors, with several notable achievements that underscore his impact:

  1. Pioneer of NGS Companies: Marco co-founded and led the development of Italy's first NGS companies, which have been instrumental in bringing transformative genomic technologies to the forefront of diagnostics.
  2. Innovative Healthcare Solutions: His work focuses on introducing cutting-edge technologies like whole genome sequencing, facilitating early detection and personalized treatment for various genetic conditions and cancers.
  3. Extensive Clinical Research Involvement: Marco has collaborated on numerous clinical research projects, contributing to advancements in understanding genetic disorders and optimizing treatments for patients.
  4. Strategic Global Partnerships: His ability to forge strategic alliances has expanded the reach and influence of the companies he has been involved with, enhancing collaboration and access to innovative solutions in healthcare.
  5. Educational Contributions: Marco has played a significant role in educating the next generation of leaders in biotechnology as a former contract professor at the University of Padova, where he shared his vast knowledge in International Business.
  6. Thought Leadership: Marco's insights into the future of genomics and healthcare technology position him as a thought leader among peers and industry professionals, maintaining his focus on patient-centric solutions.

In summary, Marco Dotto embodies the spirit of innovation and leadership in the biotechnology and healthcare sectors. His unwavering dedication to enhancing patient lives through groundbreaking technologies and strategic collaboration underscores his legacy as a transformative figure in genomics. With a robust educational foundation and significant entrepreneurial experience, Marco continues to drive positive change in health outcomes by harnessing the power of genetics and modern science.

Related Questions

How did Marco Dotto's background in biotechnology influence his approach to healthcare innovation?
What unique strategies has Marco employed in scaling his genomics companies for success?
In what ways has Marco contributed to the advancement of liquid biopsy technologies for cancer patients?
How does Marco Dotto leverage his educational background to inform his business development strategies in the healthcare sector?
What impact has Marco Dotto's work in NGS had on the field of rare disease diagnostics?
How has Marco Dotto fostered strategic partnerships to enhance his companies' capabilities in genomics?
What future trends in healthcare and genomics does Marco Dotto foresee, and how is he positioning himself to be a catalyst for these changes?
Marco Dotto
Add to my network

Location

Treviso Area, Italy